Literature DB >> 16279933

The hypocretins and sleep.

Luis de Lecea1, J Gregor Sutcliffe.   

Abstract

The hypocretins (also called the orexins) are two neuropeptides derived from the same precursor whose expression is restricted to a few thousand neurons of the lateral hypothalamus. Two G-protein coupled receptors for the hypocretins have been identified, and these show different distributions within the central nervous system and differential affinities for the two hypocretins. Hypocretin fibers project throughout the brain, including several areas implicated in regulation of the sleep/wakefulness cycle. Central administration of synthetic hypocretin-1 affects blood pressure, hormone secretion and locomotor activity, and increases wakefulness while suppressing rapid eye movement sleep. Most human patients with narcolepsy have greatly reduced levels of hypocretin peptides in their cerebral spinal fluid and no or barely detectable hypocretin-containing neurons in their hypothalamus. Multiple lines of evidence suggest that the hypocretinergic system integrates homeostatic, metabolic and limbic information and provides a coherent output that results in stability of the states of vigilance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279933     DOI: 10.1111/j.1742-4658.2005.04981.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  34 in total

Review 1.  Hypocretins in the control of sleep and wakefulness.

Authors:  Patricia Bonnavion; Luis de Lecea
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

2.  The median preoptic nucleus reciprocally modulates activity of arousal-related and sleep-related neurons in the perifornical lateral hypothalamus.

Authors:  Natalia Suntsova; Ruben Guzman-Marin; Sunil Kumar; Md Noor Alam; Ronald Szymusiak; Dennis McGinty
Journal:  J Neurosci       Date:  2007-02-14       Impact factor: 6.167

Review 3.  [The neurology of REM sleep. A synoptic tour de force].

Authors:  N J Diederich
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

4.  Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats.

Authors:  Joshi John; Lalini Ramanathan; Jerome M Siegel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

5.  Transcriptional regulation of the hypocretin/orexin gene by NR6A1.

Authors:  Susumu Tanaka; Tohru Kodama; Takashi Nonaka; Hiromi Toyoda; Makoto Arai; Miyuki Fukazawa; Yoshiko Honda; Makoto Honda; Emmanuel Mignot
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

6.  Effects of an Orexin-2 Receptor Antagonist on Sleep and Event-Related Oscillations in Female Rats Exposed to Chronic Intermittent Ethanol During Adolescence.

Authors:  Leslie R Amodeo; Derek N Wills; Manuel Sanchez-Alavez; Cindy L Ehlers
Journal:  Alcohol Clin Exp Res       Date:  2020-06-12       Impact factor: 3.455

Review 7.  Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive.

Authors:  Ada Eban-Rothschild; Lior Appelbaum; Luis de Lecea
Journal:  Neuropsychopharmacology       Date:  2017-12-05       Impact factor: 7.853

8.  Sleep-wake regulation and hypocretin-melatonin interaction in zebrafish.

Authors:  Lior Appelbaum; Gordon X Wang; Geraldine S Maro; Rotem Mori; Adi Tovin; Wilfredo Marin; Tohei Yokogawa; Koichi Kawakami; Stephen J Smith; Yoav Gothilf; Emmanuel Mignot; Philippe Mourrain
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

9.  CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.

Authors:  Mona Skard Heier; Tatiana Evsiukova; Steinar Vilming; Michaela D Gjerstad; Harald Schrader; Kaare Gautvik
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

Review 10.  Sleep and the epidemic of obesity in children and adults.

Authors:  Eve Van Cauter; Kristen L Knutson
Journal:  Eur J Endocrinol       Date:  2008-08-21       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.